• Nov. 7(Thu)
  • Nov. 8(Fri)

Nov. 7 (Thu)

Scientific Symposium 01

Current status of precision medicine in oncology area
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room A
Chair TBD
Speaker
  1. 1.Precision medicine in NSCLC: Current interpretation of biomarkers from NGS
    Myung-Ju AHN (Samsung Medical Center, Korea)
  2. 2.Precision medicine in advanced prostate cancer
    Emmanuel S. ANTONARAKIS (The Johns Hopkins University, USA)
  3. 3.Gastric cancer in the era of precision medicine
    Jeeyun LEE (Samsung Medical Center, Korea)

Scientific Symposium 02

IT biotech & digital health in oncology
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room B
Chair TBD
Speaker
  1. 1.AI, big data and oncology
    Yoon Sup CHOI (DHP, Korea)
  2. 2.Artificial intelligence for lung cancer imaging
    Kyu-Hwan JUNG (Vuno, Korea)
  3. 3.AI technologies for diagnosis of rare genetic cancer
    Changwon KEUM (3 Billion, Korea)
  4. 4.Deep learning for cancer precision medicine
    Seong Eui HONG (Theragen, Korea)

Scientific Symposium 03

Emerging strategies in immunotherapy
Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room C
Chair
  • Aung NAING (MD Anderson Cancer Center, USA)
  • Dae Ho LEE (Asan Medical Center, Korea)
  • Speaker
    1. 1.Targeting microenvironment for cancer treatment
      Aung NAING (MD Anderson Cancer Center, USA)
    2. 2.Epigenetics interplay with cancer immunotherapy
      Cathy PIETANZA (MSD, USA)
    3. 3.Co-inhibitory and co-stimulatory receptors combination in stimulating anti-tumor immunity
      Edmund K MOON (University of Pennsylvania, USA)

    Scientific Symposium 04

    State of the art on systemic therapy in HCC
    Date & Time Nov. 7 (Thu), 09:00-10:15 Venue Room D
    Chair TBD
    Speaker
    1. 1.Targeted therapy and biomarkers in hepatocellular carcinoma
      Changhoon YOO (Asan Medical Center, Korea)
    2. 2.Immunotherapy and biomarkers in hepatocellualar carcinoma
      Hong Jae CHON (CHA Bundang Medical Center, Korea)
    3. 3.Future of clinical trials in hepatocellular carcinoma
      TBD

    Plenary Lecture 01

    Date & Time Nov. 7 (Thu), 10:30-11:10 Venue Room A
    Chair Young-Hyuck IM (Samsung Medical Center, Korea)
    Speaker Targeting DNA damage repair pathway in breast cancer
    Andrew TUTT (The Institute of Cancer Research, UK)

    Presidential Sympsoium

    Date & Time Nov. 7 (Thu), 11:10-11:50 Venue Room A
    Chair Joung Soon JANG (Chung-Ang University Hospital, Korea)
    Speaker The VHL tumor suppressor gene: Insights into oxygen sensing and cancer
    William G. Kaelin, Jr. (Dana-Farber Cancer Institute, USA)

    Luncheon Symposium 1

    Date & Time Nov. 7 (Thu), 11:50-12:30 Venue TBD
    Chair TBD
    Speaker TBD

    Special Symposium

    Research, write, publish
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room A
    Chair TBD
    Speaker
    1. 1.How to accept my manuscript to the high impact journal?
      Alex A. ADJEI (Mayo Clinic, USA)
    2. 2.Doing great research and writing great papers in high impact journals
      Jeong Ho LEE (KAIST, Korea)

    Multidisciplinary Oncology Team Education Session 01 *KOR

    Immuno-oncologic therapy and pharmacologic management
    Date & Time Nov. 7 (Thu), 12:50-13:50 Venue Room C
    Chair TBD
    Speaker
    1. 1.Immune checkpoint inhibitors
      Jung Ae SEO (National Cancer Center, Korea)
    2. 2.Identification and management of toxicities with immuno-oncologic therapy
      Juhyang CHEON (Yeungnam University Hospital, Korea)
    3. 3.Oncology pharmacist’s role in immuno-oncologic therapy
      Soyeon HONG (Seoul National University Bundang Hospital, Korea)

    ASCO/KSMO Joint Symposium

    Progress in precision medicine through global collaboration
    I. Utilization of NGS to improve patient care
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room A
    Chair
  • Edward Sanghyun KIM (Levine Cancer Institute, USA)
  • Yung-Jue BANG (Seoul National University Hospital, Korea)
  • Speaker
    1. 1.Precision genomics-based patients’ care - ASCO’s TAPUR study
      Edward Sanghyun KIM (Levine Cancer Institute, USA)
    2. 2.Clinical applications of NGS in Korea
      Tae-You KIM (Seoul National University Hospital, Korea)
    3. 3.Global collaboration in genomic data sharing and use
      Subha MADHAVAN (Georgetown University, USA)

    Scientific Symposium 05

    Modulating microenvironment for cancer treatment
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room B
    Chair TBD
    Speaker
    1. 1.STING signaling regulates immune-vascular crosstalk to enhance anti-tumor immunity
      Chan KIM (CHA Bundang Medical Center, Korea)
    2. 2.Immune surveillance and the role of the endogenous angiogenesis inhibitors thrombospondin-1 and endostatin in tumor immunity
      Sandra RYEOM (UPENN, USA)
    3. 3.Leverages advanced technologies to investigate microbiomes and their clinical impact
      Julia OH (The Jackson Laboratory, USA)

    KOSRO/KSMO Joint Symposium

    The promise of combining RT and Immunotherapy
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room C
    Chair
  • David RABEN (University of Colorado, USA)
  • In Ah KIM (Seoul National University Bundang Hospital, Korea)
  • Speaker
    1. 1.Radiotherapy and Immunotherapy - New strategy for better outcome
      David RABEN (University of Colorado, USA)
    2. 2.Radiotherapy and Immunotherapy - On ongoing clinical trial
      Jin Ho KIM (Seoul National University Hospital, Korea)
    3. 3.Toxicities of the combination of radiotherapy and immunotherapy
      Keun-Wook LEE (Seoul National University Bundang Hospital, Korea)

    Multidisciplinary Oncology Team Education Session 02 *KOR

    Oncology nursing care in immune-oncology and targeted agent
    Date & Time Nov. 7 (Thu), 14:10-15:40 Venue Room D
    Chair TBD
    Speaker
    1. 1.Principles of clinical advances of molecular targeted agent
      Moon Ki CHOI (National Cancer Center, Korea)
    2. 2.Principles of clinical advances of I-O
      Eun Joo KANG (Korea University Guro Hospital, Korea)
    3. 3.Management of molecular targeted agent-related AEs
      Jae Ho JEONG (Asan Medical Center, Korea)
    4. 4.Management of immune-related AEs
      Yun-Gyoo LEE (Kangbuk Samsung Hospital, Korea)

    ASCO/KSMO Joint Symposium

    Progress in precision medicine through global collaboration
    II. Integrated platform for precision medicine
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room A
    Chair TBD
    Speaker
    1. 1.Integrated precision medicine platform for data-sharing in USA
      TBD
    2. 2.How can we incorporate NGS data-sharing platform for precision medicine in Korea?
      Woong Yang PARK (Samsung Medical Center, Korea)
    3. 3.KSMO-KCSG Korean precision medicine networking group initiative
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)

    Scientific Symposium 06

    Translational Research - Biomarker studies to achieve desired clinical applications
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room B
    Chair
  • Patrick TAN (Duke-NUS Medical School, Singapore)
  • Yeul Hong KIM (Korea University Anam Hospital, Korea)
  • Speaker
    1. 1.Development of CDK4/6 inhibitor for solid tumor
      Richard FINN (UCLA, USA)
    2. 2.Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma: insights for novel targeted therapies
      Qiang PAN-HAMMARSTRÖM (Karolinska Institutet, Sweden)
    3. 3.Genomic predictors of clinical prognosis in gastric cancer
      Patrick TAN (Duke-NUS Medical School, Singapore)

    Scientific Symposium 07

    GY cancer multimodality treatment
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room C
    Chair TBD
    Speaker
    1. 1.The role of PARPi in ovarian cancer
      Keun Ho LEE (The Catholic University of Korea Seoul St. Mary's Hospital's Hospital, Korea)
    2. 2.IO for ovarian cancer  
      Gun Min KIM (Yonsei Cancer Center, Korea)
    3. 3.Combination of PARP inhibitors and Immune checkpoint inhibitors in ovarian cancer 
      Jung-Min LEE (National Cancer Institute, USA)
    4. 4.International collaboration in GY cancer clinical research
      Elise C. KOHN (National Cancer Institute, USA)

    KCCA Symposium

    The Current State and System of Overseas Drug Accessibility
    Date & Time Nov. 7 (Thu), 16:00-17:30 Venue Room D
    Chair TBD
    Speaker
    1. TBD

    Nov. 8 (Fri)

    Scientific Symposium 08

    Partnering between biotechs and investigators in early phase drug development
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room A
    Chair
  • Tae Won KIM (Asan Medical Center, Korea)
  • Stefan GLÜCK (GMA Oncology & Early Assets, USA)
  • Speaker
    1. 1.How to navigate turbulent biotech as an investigator?
      James Jungkue LEE (Bridge Biotherapeutics, Inc., Korea)
    2. 2.PharmAbcine story and its Perspective in Oncology
      Jin-San YOO (PharmAbcine, Korea)
    3. 3.Looking inside from outside: MD perspective
      Hansoo PARK (Genome & Company, Korea)

    Scientific Symposium 09

    Precision oncology and cancer epigenetics
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room B
    Chair TBD
    Speaker
    1. 1.Understanding and targeting the epigenome in liver cancer
      Keith D. ROBERTSON (Mayo Clinic, USA)
    2. 2.Molecular mechanism underlying epigenetic carcinogenesis
      Young-Joon KIM (Yonsei University, Korea)
    3. 3.Treatment strategy targeting epigenetic mechanism in cancer
      Young-Hyeh KO (Samsung Medical Center, Korea)

    KCSG/KSMO Joint Symposium

    Multidisciplinary efforts for awareness and minimizing toxicities from systemic cancer therapy
    Date & Time Nov. 8 (Fri), 09:00-10:30 Venue Room C
    Chair TBD
    Speaker
    1. 1.Endocrinopathy
      Tae Jung OH (Seoul National University Bundang Hospital, Korea)
    2. 2.Cardiovascular problems (CHF, arrhythmia etc)
      TBD
    3. 3.Pulmonology
      Eric LANCASTER (UPENN, USA)
    4. 4.Neurologic problems
      Jin-Hyoung KANG (The Catholic University of Korea Seoul St. Mary's Hospital, Korea)

    Plenary Lecture 02

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
    Chair TBD
    Speaker Past, present and future of geriatric oncology
    Andrew TUTT (The Institute of Cancer Research, UK)

    Noe Kyeong Kim Memorial Award & Lecture

    Date & Time Nov. 8 (Fri), 11:30-12:10 Venue Room A
    Chair TBD
    Speaker TBD

    Luncheon Symposium 3

    Date & Time Nov. 8 (Fri), 12:10-12:50 Venue TBD
    Chair TBD
    Speaker TBD

    Plenary Lecture 03

    Date & Time Nov. 8 (Fri), 10:50-11:30 Venue Room A
    Chair TBD
    Speaker The reality versus potential of immune check-point inhibitors as cancer therapeutics
    Heather WAKELEE (Stanford University , USA)

    JSMO/KSMO Joint Symposium

    Clinical Trials in Asia: Opportunities and Challenges
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room A
    Chair TBD
    Speaker
    1. 1.How to make the biopharma companies to decide to conduct clinical trials in Asia?
      Takayuki YOSHINO (National Cancer Center Hospital East, Japan)
    2. 2.Early clinical research capabilities in Japan
      Toshio SHIMIZU (National Cancer Center Hospital Japan, Japan)
    3. 3.Early clinical research capabilities in Korea
      Do-Youn OH (Seoul National University Hospital, Korea)
    4. 4.JSMO-KSMO collaboration for clinical trials
      Sun Young RHA (Yonsei Cancer Center, Korea)

    Scientific Symposium 10

    Geriatric Oncology
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room B
    Chair TBD
    Speaker
    1. 1.Geriatrics for oncologists
      Kwang Il KIM (Seoul National University Hospital, Korea)
    2. 2.Predicting outcome of older patients with cancer – Sharing Korean experiences
      Jee Hyun KIM (Seoul National University Bundang Hospital, Korea)
    3. 3.How to improve cancer care for older patients - Sharing Singaporian experiences
      Ravindran KANESVARAN (National Cancer Centre Singapore, Singapore)
    4. 4.Breast cancer in older women
      Hans WILDIERS (University Hospitals Leuven, Belgium)

    Scientific Symposium 11

    Evolving strategies for surgery and systemic therapy in the neoadjuvant treatment era
    Date & Time Nov. 8 (Fri), 14:00-15:30 Venue Room C
    Chair TBD
    Speaker
    1. 1.Neoadjuvant treatment for gastric cancer in Western countries
      TBD
    2. 2.Neoadjuvant treatment for gastric cancer in East Asian countries
      Masanori TERASHIMA (Shizuoka Cancer Center, Japan)
    3. 3.Conversion surgery in metastatic gastric cancer
      Eun-Kee SONG (Chonbuk National University Hospital, Korea)

    KSP/KSMO Joint Symposium

    Immune Biomarker
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room A
    Chair TBD
    Speaker
    1. 1.MSI-H in pan-tumor
      Patricia MARINELLO (MSD, USA)
    2. 2.TMB: the role in IO prediction
      Ji-hun KIM (Asan Medical Center, Korea)
    3. 3.PD-L1 in routine practice
      Tae-Jung KIM (The Catholic University of Korea Yeouido St. Mary's Hospital, Korea)
    4. 4.Multiplex immunoprofiling in cancer
      Hee Jin LEE (University of Ulsan College of Medicine, Korea)

    Scientific Symposium 12

    Radiomics: Primer for medical oncologists
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room B
    Chair TBD
    Speaker
    1. 1.Radiomics and Deep learning in Differential Diagnosis and Molecular Classification
      Ji Eun PARK (Asan Medical Center, Korea)
    2. 2.Radiomics and Deep Learning in Monitoring Treatment Response
      Philipp KICKINGEREDER (Heidelberg University Hospital, Germany)
    3. 3.Oncologist's view of radiomics
      Kyu Pyo KIM (Asan Medical Center, Korea)
    4. 4.Radiomics in thoracic oncology
      Ho Yun LEE (Samsung Medical Center, Korea)

    Oncology Multi-disciplinary Symposium

    Multi-disciplinary Discussion on the Reimbursement Criteria of Imaging Studies in Cancer Patients
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room C
    Chair TBD
    Speaker TBD

    Multidisciplinary Oncology Team Education Session 03 *KOR

    CRC/CRA in clinical trial of precision medicine
    Date & Time Nov. 8 (Fri), 15:50-17:20 Venue Room D
    Chair
  • Hwan Jung YUN (Chungnam National University Hospital, Korea)
  • Seok Yun KANG (Ajou University Hospital, Korea)
  • Speaker
    1. 1.Recent trend of clinical trials in a precision medicine era
      Jeong Eun KIM (Asan Medical Center, Korea)
    2. 2.Real experience of a basket trial
      Min Hwan KIM (Yonsei Cancer Center, Korea)
    3. 3.Real experience of a umbrella trial: TRIUMPH trail in H&N cancer, biomarker-integrated umbrella, advanced gastric cancer
      Hee Kyung AHN (Gachon University Gil Medical Center, Korea)